Inhibrx Biosciences, Inc. (INBX)
NASDAQ: INBX · Real-Time Price · USD
12.56
-0.24 (-1.88%)
Feb 21, 2025, 4:00 PM EST - Market closed
Inhibrx Biosciences Market Cap
Inhibrx Biosciences has a market cap or net worth of $181.82 million as of February 21, 2025.
Market Cap
181.82M
Enterprise Value
-12.68M
1-Year Change
n/a
Ranking
Category
Stock Price
$12.56
Market Cap Chart
Since the IPO on May 29, 2024, Inhibrx Biosciences's market cap has decreased from $198.24M to $181.82M, a decrease of -8.28%. That is a compound annual growth rate of -11.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 181.82M | -18.44% |
| Dec 31, 2024 | 222.93M | 12.46% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |